BRCA2 and neoplasm: Although promoter methylation of BRCA1 and of BRCA2 gene has not been widely assessed in ovarian cancers, this mechanism is well known to affect other tumor suppressor genes, and, importantly, it is easy to detect in routine diagnostics even when FFPE tumor tissue is the only available material.